Operating Income (Loss) in USD of KESTRA MEDICAL TECHNOLOGIES, LTD. from 2023 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Kestra Medical Technologies, Ltd. quarterly/annual Operating Income (Loss) history and growth rate from 2023 to Q2 2025.
  • Kestra Medical Technologies, Ltd. Operating Income (Loss) for the quarter ending July 31, 2025 was -$28.9M, a 56.7% decline year-over-year.
  • Kestra Medical Technologies, Ltd. annual Operating Income (Loss) for 2024 was -$106M, a 25.1% decline from 2023.
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)

KESTRA MEDICAL TECHNOLOGIES, LTD. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 -$28.9M -$10.4M -56.7% May 1, 2025 Jul 31, 2025 10-Q 2025-09-12
Q2 2024 -$18.4M May 1, 2024 Jul 31, 2024 10-Q 2025-09-12

KESTRA MEDICAL TECHNOLOGIES, LTD. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$106M -$21.3M -25.1% May 1, 2024 Apr 30, 2025 10-K 2025-07-17
2023 -$85.1M May 1, 2023 Apr 30, 2024 10-K 2025-07-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.